BIB ETF is best suited for high-risk, active investors in the accumulation phase or retirees managing portfolios hands-on.

The goal of gene therapy is to permanently cure hereditary diseases. One of the most promising technologies for this is the ...

Oslo (Norway), 23 October 2025 - PCI Biotech (OSE: PCIB) today provides an update on the ongoing evaluation of its operations.

Bahrain is licensing SandboxAQ’s software and expertise in quantitative AI to identify and develop targets and novel ...

KRTL Holding Group Inc. (OTC: KRTL) ('KRTL Holding' or the 'Company') today announced that its majority-owned subsidiary, KRTL Biotech, Inc., is highlighting its expanded portfolio of anti-infective ...

The complex and costly journey of oncology drug development is reliant on robust and comprehensive clinical data. Early-stage ...

Outstanding measure of efficacy relative to high-risk cancers with limited treatment options CHICAGO, Oct. 23, 2025 (GLOBE NEWSWIRE) -- MAIA Biotechnology, Inc. (NYSE American: MAIA) ("MAIA", the "Com ...

When members of the Baldwin High School Class of 1983 held their 30-year reunion, Doug Strott declined to attend. “I was ...

Oncolytics Biotech® Inc. (NASDAQ: ONCY) (“Oncolytics” or the “Company”), a clinical-stage immunotherapy company developing ...

Pedersen, Louise Rasmussen and Maggie Fick COPENHAGEN (Reuters) -Denmark's Novo Nordisk launched a rival bid for U. obesity ...

Still, the recently released 2025-30 Arizona Bioscience Roadmap, as well as several academic, community and local government ...